ABN Clinical Guidelines

• ABN guidelines for treatment of multiple sclerosis with Beta Interferon and Glatirmer acetate
  ABN, March 2007
• ABN stem cell statement
  ABN, March 2007
• Intravenous immunoglobulin in neurological diseases
  ABN, July 2005
• The medical management of motor neurone disease - a UK perspective of current practice
  ABN, September 2002
• Beta-interferon & Glatiramer acetate in multiple sclerosis
  ABN, January 2001
• Management of motor neuron disease (ALS)
  ABN, June 1999

ABN Publications

• ABN Response to the NSF for Long Term Conditions
  ABN, November 2007
• Job Planning and the New Consultant Contract
  ABN, revised July 2006
• Learning about Disorders of the Nervous System
  ABN, May 2006
• General medical components of Neurology training
  ABN, April 2006
• Academic neurology in the United Kingdom - threats, opportunities and recommendations
  2004, ABN
  Download: Shortened version WITHOUT appendices
  Download: Full version WITH appendices
• Critical Care for Neurology Patients [members only]
  ABN position paper on critical care for people with neurological disorders
  2003, ABN
• UK Neurology - The Next Ten Years
  2003, ABN
• Genetic Services for Neurological Disorders
  2003, ABN, Report of a working group of the Association of British Neurologists and Clinical Genetics Society
• Acute Neurological Emergencies in Adults
  2002, ABN, Report of a working party on care of neurological emergencies
• Neurology in the UK: towards 2000 and beyond
  1997, ABN
• Neurology in the UK: numbers of clinical neurologists and trainees
  1996, ABN
• The place of research in the training of Neurologists
  1995, ABN
• Teaching Neurology in the 21st century
  1994, ABN